Carlyle Group’s OnKure Therapeutics OKUR Stock Holding History

Carlyle Group’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$735K	Hold	269,895	–	–	0.01%	11
2026 Q2	$1.23M	Hold	269,895	–	–	0.01%	11
2026 Q1	$1.12M	Hold	269,895	–	–	0.01%	13
2025 Q4	$772K	Hold	269,895	–	–	0.01%	14
2025 Q3	$742K	Hold	269,895	–	–	0.02%	15
2025 Q2	$642K	Hold	269,895	–	–	0.01%	18
2025 Q1	$1.16M	Hold	269,895	–	–	0.03%	19
2024 Q4	$2.33M	Sell	269,895 -1	-0%	-$15	0.06%	19
2024 Q3	$4.53M	Hold	269,896	–	–	0.48%	12
2024 Q2	$4.16M	Hold	269,896	–	–	0.39%	15
2024 Q1	$4.45M	Hold	269,896	–	–	0.28%	17
2023 Q4	$4.32M	Hold	269,896	–	–	0.21%	16
2023 Q3	$20.5M	Hold	269,896	–	–	0.89%	11
2023 Q2	$17.7M	Buy	269,896 +62,500	+30%	+$5.04M	0.63%	11
2023 Q1	$12.2M	Buy	+207,396	New	+$7.52M	0.37%	14

Other funds holding OKUR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

Carlyle Group's OKUR Position: Q3 2026 in Review

Carlyle Group held its OnKure Therapeutics (OKUR) position steady in Q3 2026 at 269,895 shares worth $735K. The position accounts for 0.01% of the portfolio, ranked #11.

Carlyle Group first reported a position in OKUR in Q1 2023 and has held it in 15 quarters since. The position peaked at $20.5M in Q3 2023. 18 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

Carlyle Group held 269,895 shares of OnKure Therapeutics worth $735K as of Q3 2026.
Carlyle Group left its OnKure Therapeutics share count unchanged in Q3 2026.
OnKure Therapeutics made up 0.01% of Carlyle Group's portfolio in Q3 2026, its #11 holding.
Carlyle Group first reported a position in OnKure Therapeutics in Q1 2023 and has held it in 15 quarters since.
Carlyle Group's OnKure Therapeutics position peaked at $20.5M in Q3 2023.
18 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Carlyle Group's 13F filing for Q3 2026, filed 6 Nov 2026.